Skip to main content
OpenTrials
Completed

NCT Number: NCT05565339

PMEI Post-Market Clinical Follow-Up

Confirm safety and performance of passive middle ear implants (PMEIs) in subjects with pre-existing condition which made the implantation of a MED-EL PMEI necessary

Completed

Looking for future studies?

Notify Me

Key information

Age range

0 year–99 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Linz Kepler Universitätsklinikum GmbH, Klinik für Hals-, Nasen- und Ohrenheilkunde, Linz, Upper Austria, Austria

Loading trial locations.

About this study

Collect retrospective audiological and safety results of PMEI implanted subjects. A post-operative minimum and maximum follow-up period was not defined. The mean of the post-operative follow-up period of all patients was calculated.

Who can participate

Only the study team can determine whether someone qualifies for participation.

  • Inclusion Criteria: Implanted with a MED-EL PMEI; initial implantation or revision implantation receiving a MED-EL PMEI
  • Exclusion Criteria: None

Treatment and study plan

PMEIs

Device

To evaluate audiological outcomes post-operatively, the air-bone gap (ABG) was assessed.

To evaluate safety of the devices, adverse events were collected.A post-operative minimum and maximum follow-up period was not defined. The mean of the post-operative follow-up period of all patients was calculated. To assess whether implantation of PMEI affected residual hearing pre- and post-operative bone conduction thresholds were evaluated.

Primary outcomes

  1. ABG

    Time frame: A post-operative minimum and maximum follow-up period was not defined.

    To collect post-operative PTA4 ABG results. It was expected to achieve a post-operative ABG ≤ 20 dB with a PMEI, by at least 25 % of the total ossicular replacement prostheses patients, by at least 53.8 % of the partial ossicular replacement prostheses patients, and by at least 86 % of the stapes prostheses patients.

Secondary outcomes

  1. adverse events

    Time frame: A post-operative minimum and maximum follow-up period was not defined.

    To collect device, surgery or procedure related adverse events and bone conduction thresholds

Sponsors and collaborators

Lead sponsor

MED-EL Elektromedizinische Geräte GesmbH

Industry

Registry information

Important dates

Study start
2020
Primary completion
2023
Study completion
2023
First posted
Oct 4, 2022
Registry last updated
Dec 15, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.